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Some of the universal characteristics of pre-agricultural hominin diets are strikingly different from the 
modern human diet. Hominin dietary choices were limited to wild plant and wild animal foods, while the 
modern diet includes more than 70 % of energy consumed from refined sugars, refined vegetable oils, and 
highly processed cereals and dairy products. The modern diet, with higher intake of fat has also resulted 
in a higher ratio of omega-6 (n-6) to omega-3 (n-3) polyunsaturated fatty acids (PUFA), contributing to 
low-grade chronic inflammation (LGCI) and thus promoting the development of many chronic diseases, 
including obesity and osteoporosis. In this review, we describe the changes in modern diet, focusing on 
the kind and amount of consumed fat; explain the shortcomings of the modern diet with regard to 
inflammatory processes; and delineate the reciprocity between adiposity and inflammatory processes, with 
inflammation being a common link between obesity and osteoporosis. We present the evidence that over-
consumption of n-6 PUFA coupled with under-consumption of n-3 PUFA results in LGCI and, along with 
the increased presence of reactive oxygen species, leads to a shift in mesenchymal stem cells (precursors 
for both osteoblasts and adipocytes) lineage commitment toward increased adipogenesis and suppressed 
osteoblastogenesis. In turn, high n-6 to n-3 PUFA ratios in the modern diet, coupled with increased synthesis 
of pro-inflammatory cytokines due to adiposity, propagate obesity and osteoporosis by increasing or 
maintaining LGCI.
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Dietary intake and other lifestyle factors (e.g. 
physical activity, smoking) are environmental modifiers 
that have changed dramatically with agriculture and 
animal husbandry, about 10,000 years ago (1, 2). 
However, a number of anthropological, nutritional, and 
genetic studies indicate that even more drastic changes 
happened very recently, some 200 years ago with the 
onset of industrial revolution, and that these changes 
could be associated with many chronic diseases or the 
so-called diseases of civilization (1, 3).
By examining the dietary habits along the 
evolutionary timeline, one can easily notice the 
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difference between the pre-agricultural hominine and 
modern human diet. Hominin dietary choices were 
limited to wild plant and animal foods. In contrast, 
72 % of the energy consumed by modern humans 
includes refined sugars, refined vegetable oils, highly 
processed cereals and dairy products, as well as high 
consumption of alcohol (4).
The objectives of this review are to: a) describe 
the changes in modern diet with regard to several 
nutrients, particularly addressing the type and amount 
of consumed fat; b) explain the shortcomings of the 
modern diet with regard to inflammatory processes; 
and c) delineate the reciprocity between adiposity and 
inflammatory processes and the link that connects 
obesity, osteoporosis, and inflammation. We present 
the hypothesis that omega-6 (n-6) polyunsaturated 
fatty acids (PUFA) propagate obesity and osteoporosis 
by increasing/maintaining low-grade chronic 
inflammation (LGCI), ultimately shifting the 
commitment of mesenchymal stem cells (MSC) 
toward increased adipogenesis.
Discordance between current and past dietary 
habits along the evolutionary timeline
Our genetic makeup has not changed over the last 
few centuries, but the environment and dietary 
behaviors have, substantially. The spontaneous 
mutation rate for nuclear DNA is estimated at 0.5 % 
per million years; thus, very little change has occurred 
in our genes compared to our Paleolithic ancestors of 
40,000 years ago, when our genetic profile was 
established. Therefore, the profound environmental and 
dietary changes that began with the introduction of 
agriculture and animal husbandry some 10,000 years 
ago, occurred too recently on the evolutionary timeline 
for the human genome to adapt, contributing to many 
of the chronic diseases in modern societies (5).
Some nutrients exhibit high discordance regarding 
their intake in the hominines compared to modern 
humans that may have contributed to inflammation 
and subsequent chronic diseases, including obesity 
and osteoporosis. Of note are the lower consumption 
of fat, carbohydrates, and sodium (high amounts of 
the latter might result in negative consequences on 
bone health via increased calcium excretion) and much 
higher consumption of calcium and vitamin C (both 
important in bone health and the former one in weight 
management). Additionally, with the high intake of 
plant foods, hominines were consuming much higher 
amounts of fiber (has a role in weight management) 
and phytochemicals, known for their anti-oxidative 
and anti-inflammatory properties. Table 1 compares 
the intake of hominines and current intake in the USA, 
as well as the current recommendations of selected 
nutrients in the USA (adapted from 2, 6, 7).
Changes in fat intake and their subsequent effect on 
omega-6 (n-6) and omega-3 (n-3) PUFA ratio
Among the most salient changes were those in the 
dietary fat intake, specifically in the type and amount 
of fatty acids (1, 3, 8). The amount and kind of fat 
reflected the consumption of primarily lean meat from 
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Table 1 Estimated intake of selected nutrients and foods by hominines from the late Paleolithic (~40,000 years ago) and modern 
USA population and current recommendations 
Nutrients/ Foods Late Paleolithic Current USA Intake
Current USA 
recommendations
Fat (% of energy) 21 33 20-35
Carbohydrates (% of energy) 46 50 45-65
Protein (% of energy) 33 15 10-35
Alcohol (serving per day) Minimal N/A 1-2
P/S ratio 1.4 0.7 N/A
Cholesterol (mg per day) 520 261 <300
Fiber (mg per day) 100-150 16 38
Sodium (mg per day) 690 3463 <2300
Calcium (mg per day) 1500-2000 1029 1000-1300
Vitamin C (mg per day) 440 87 75-95
Adapted from references (2, 6, 7)
P/S - polyunsaturated to saturated fatty acid ratio; N/A - data not available
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wild animals, low in saturated fatty acids (SFA) and 
high in both PUFA and monounsaturated fatty acids 
(MUFA), with low n-6 to n-3 PUFA ratio. Prior to the 
Neolithic (agricultural) period, or some 40,000 years 
ago in the Paleolithic, all animal foods consumed by 
hominines were limited to wild animals (9). 
Approximately 50 % of fatty acids in the adipose tissue 
of wild animals were SFAs, while the dominant type 
in the muscle and all other organs were PUFA and 
MUFA. However, for most of the year animals’ 
subcutaneous and visceral body fat stores were usually 
depleted, and it was likely that PUFA and MUFA were 
the predominant fats of the carcass available for 
hominin consumption. Therefore, high amounts of 
SFA were probably not available to hominines feeding 
on these wild animals. Moreover, the consumption of 
seeds, nuts, various greens, and other wild plants 
provided the hominines with higher intake of PUFAs 
and MUFAs and probably with an optimal ratio of n-6 
to n-3 (3, 8).
Subsequent changes that occurred with the 
beginning of animal husbandry and agriculture (in the 
Neolithic period, some 10,000 years ago) allowed for 
slaughtering of animals at the peak of body fat 
accumulation, while the production of grains and other 
agricultural products with higher SFA content led to 
an increasing consumption of n-6 PUFAs, creating a 
less favorable n-6 to n-3 ratio. Technological advances 
in the early and mid 19th century generated large 
quantities of grain (especially corn) for animals and 
humans, which changed the composition of the meat 
in the cattle, resulting in “marbled meat” characterized 
by excessive triglyceride accumulation and fat 
infiltration into the muscular tissue and higher SFA 
content (10). This and the modernization of food 
processing and preservation, as well as changes in 
food choices have altered the ratio between n-6 and 
n-3 fatty acids in the modern diet and resulted in its 
low n-3 fatty acid content (8, 9), favoring the 
development of chronic diseases.
According to numerous anthropological and 
epidemiological studies, humans evolved on a diet 
with a n-6 to n-3 PUFA ratio of approximately 1-2:1 
(3), whereas this ratio in the current Western-type diet 
has increased to approximately 10-15:1 (1, 3, 8), as 
shown in Table 2 (adapted from 1, 3, 8). This suggests 
that even the current dietary guidelines (except for the 
recommendations from the American Heart Association 
for severe coronary patients, who need to lower their 
triglycerides) fall short of the intake of prehistoric 
humans. Table 3 (adapted from 1, 3, 8, 11) shows 
different recommendations for eicosapentanoic acid 
(EPA) and docosahexanoic acid (DHA) as well as the 
n-6 to n-3 ratio. The Lyon Diet Heart Study (12) 
showed that the ratio of 4:1 could be cardioprotective. 
The subjects in this study consumed less linoleic acid 
(n-6) and more of oleic (n-9) MUFA and α-linolenic 
acid (n-3), which resulted in higher plasma levels of 
oleic acid, linolenic acid, and EPA and lower levels 
of linoleic and arachidonic acid (AA), which was 
ultimately associated with a reduced risk of recurrent 
heart disease.
Pro- and anti-inflammatory metabolites of n-6 and 
n-3 fatty acids
It is known that elevated n-6 PUFA levels stimulate 
pro-inflammatory processes and promote the 
pathogenesis of many diseases such as cardiovascular, 
neurological, autoimmune, as well as cancer, arthritis, 
and diabetes (3, 8). Recently however, it has been 
realized that various pro-inflammatory actions may 
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Table 2 Ratio between n-6 and n-3 polyunsaturated fatty acids 
in different population groups
Population group n-6/n-3 ratio
Paleolithic/Neolithic 0.8-1
Mediterranean (prior to 1960) 1-2
Current Northern Europe 15
Current USA 15-20
Adapted from references (1, 3, 8)
Table 3 Intake of eicosapentanoic acid (EPA) and 















AHA (severe coronary 
patients) 2-4 3:1
FDA GRAS level 3 N/A
Adapted from references (1, 3, 8, 11)
NHANES - National Health and Nutrition Examination Survey;
AHA - American Heart Association
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foster obesity and osteoporosis as well (11). In 
contrast, n-3 fatty acids and their derivatives have been 
shown to promote anti-inflammatory processes and to 
have some beneficial health effects on cardiovascular 
disease (8, 9), cognition in aging, function in the brain 
grey matter, and the development of eye retina (2, 8).
Eicosanoids, the metabolic products of the 
sequential elongation and desaturation processes of 
both n-6 and n-3 PUFA, are the signaling molecules 
responsible for the immune and inflammatory 
reactions in the body (13). They originate from the 
essential fatty acids, linoleic (n-6) and alpha linolenic 
(n-3). The major metabolites of n-6 PUFA are pro-
inflammatory eicosanoids and include prostaglandin 
E2 (PGE2), leukotriene B4 (LBT4), and thromboxane 
A2 (TXA2), generated by lipid-oxidizing enzyme 
lipoxygenase-5 (5-LOX) and cyclooxygenase-2 
(COX-2) (13). The major metabolites of n-3 PUFA 
are the anti-inflammatory eicosanoids and include 
prostaglandin E3 (PGE3), leukotriene B5 (LBT5), 
resolvins, and protectins, also generated by COX-2 
and 5-LOX. During metabolism, n-6 and n-3 PUFAs 
compete for the desaturation enzymes (13, 14), and 
the higher amount of n-6 PUFA in the modern diet 
shifts the balance toward the production of pro-
inflammatory eicosanoids (11). Figure 1 illustrates the 
metabolic pathways of the n-6 and n-3 PUFA series 
in generating various types of eicosanoids.
Acute and low-grade chronic inflammation and 
their resolutions
The breakdown of fatty acid metabolites and the 
conversion of eicosanoids generates different pro- and 
anti-inflammatory products (Figure 2). The pro-
inflammatory lipoxins A4 and B4 are the metabolites 
of AA, and their action is focused on neutrophil 
regulation (15), while the E-series resolvins (both E1 
and E2) are metabolized from EPA by 5-LOX, and 
their action is anti-inflammatory (16). Protectins, the 
D-series resolvins (D1 and D2), and the macrophage-
specific maresins are the metabolites of DHA (17), 
and these are associated with resolving the inflammation 
(18). Overall, n-3 PUFA are metabolized into anti-
inflammatory eicosandoids which are important to 
resolve inflammation otherwise triggered by any insult 
on the cell, ranging from a bruise to a bacterial 
infection or even by inflammatory signals from 
neighboring cells.
Acute inflammation activates the inflammatory 
cascade of prostaglandins, leukotrienes, and other 
inflammatory cytokines such as tumor necrosis factor-
alpha (TNF-α), interleukin-6 (IL-6), and interferon-
gamma which recruit neutrophils and macrophages. 
When the insult is dealt with, either via apoptosis and 
phagocytosis of the infected cells and foreign bodies 
or via cleaning the local inflammation, resolvins, 
protectins, maresins, and lipoxins all work together to 
stop further recruitment of immune cells and the 
propagation of pro-inflammatory cytokines, so that 
the cell can return to its basal state (19, 20).
In contrast, LGCI is a state of persistent and 
unresolved inflammation, where pro- and anti-
inflammatory cytokines are elevated, and inflammation 
is not resolved (21). In the clinical context, this state 
results from the continuous presence of specific 
immune cells leading to 2-4-fold elevations in the 
circulating levels of pro- and anti-inflammatory 
cytokines, and more are recruited in a perpetual cycle 
(21). The exact PUFA metabolite composition of this 
unresolved or surplus inflammation is unknown (17), 
but it is likely that there is a bias towards the pro-
inflammatory eicosanoids, particularly with higher 
n-6 PUFAs intake (Figure 3).
The detrimental role of low-grade chronic 
inflammation in obesity and osteoporosis
Obese individuals have abnormal circulating levels 
of TNF-α, IL-6, C-reactive protein (C-RP), adiponectin, 
and leptin, as these molecules are overexpressed in 
adipose tissue (22-24). PGE2, a metabolite of AA, has 
been found to mediate locally the biological action of 
TNF-α and Interleukin-1 (IL-1) in the cases of fever 
and local inflammation. Leptin and adiponectin are 
adipokines produced by adipose tissue that mediate 
chronic inflammation. Leptin has been found to 
stimulate inflammatory responses (25, 26), while 
adiponectin acts as an anti-inflammatory adipokine 
(27). The constant presence of these inflammatory 
cytokines associated with increased adiposity 
promotes persistent LGCI in obese individuals (1), 
while adipose tissue itself increases their production, 
resulting in a perpetual feedback cycle from one to 
another (adiposity↔inflammation). For more 
extensive review see Kelly et al. (11).
In the bone, inflammation also plays a detrimental 
role and is interconnected with adiposity. It is well 
established that IL-6 stimulates osteoclastogenesis 
(formation of bone-resorbing cells) and is considered 
an osteoresorptive factor (28). Simultaneously, higher 
amount of fat mass activates osteoclasts via increase 
in other cytokines like IL-1 and TNF-α, as shown in 
Figure 4. Osteoclasts are derived from the same 
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hematopoietic stem cells as the immune cells (29). In 
LGCI accompanied by increased T-cell activation, 
osteoclastogenesis and bone resorption are accelerated, 
as the osteoclasts are programmed to respond to 
inflammatory signals. Therefore, in states such as 
LGCI, osteoclastogenesis and bone resorption are 
increased (11), leading to a perpetual feedback cycle 
(bone resorption↔inflammation).
Mesenchymal stem cells (MSC) are the common 
precursors for osteoblasts (bone forming cells) and 
adipocytes (30). However, inflammation may 
deregulate the MSC lineage commitment (11, 31). 
Even under normal homeostatic conditions, MSC 
slightly favors adipogenic differentiation. In LGCI, 
pro-inflammatory mediators in the presence of a high 
n-6 to n-3 ratio and reactive oxygen species (ROS), 
stimulate adipogenesis and suppress osteoblastogenesis, 
ensuring that MSC are committed to becoming 
adipocytes. In addition, high levels of IL-6, C-RP, and 
TNF-α are associated with lower muscle mass in older 
people (32). Since muscle and bone mass decline with 
age, and fat mass increases, it is possible that age-
related MSC lineage commitment dysfunction 
occurring in LGCI and coinciding with obesity causes 
both osteopenia (loss of bone) and sarcopenia (loss of 
muscle). For the extensive review on the connection 
between bone, muscle, and fat, see Ilich et al. (31).
Recently, we investigated the effect of n-6 and n-3 
PUFAs in different ratios on MSC proliferation and 
differentiation and found that the n-6 to n-3 ratio of 
4:1 resulted in maximal osteoblastogenesis and 
minimal adipogenesis in a cell culture system (33). 
This ratio is higher than in the prehistoric humans (e.g. 
1:1), and is feasible for modern humans with some 
dietary modifications. Figure 5 illustrates the loop 
effect of modern (A) and prehistoric (B) diet on 
a d i p o g e n e s i s ,  o s t e o b l a s t o g e n e s i s ,  a n d 
osteoclastogenesis.
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Figure 1 Metabolism of essential linoleic (n-6) and alpha linolenic (n-3) fatty acids. An overproduction of arachidonic 
acid originating from the high intake of linoleic acid will metabolize into pro-inflammatory eicosanoids, which are 
implicated in many inflammatory and autoimmune disorders. Eicosapentanoic acid (EPA) and docosahexanoic acid 
(DHA), which are the derivatives of the essential n-3 alpha linolenic fatty acid (created from multiple elongation and 
desaturation reactions), form anti-inflammatory eicosanoids
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Proposed mechanism of action
The enzyme COX-2 has a higher affinity for n-6 
than n-3 PUFAs and the former will be metabolized 
at a higher rate (13, 14). However, higher presence of 
n-3, especially at the 1:1 ratio, would increase the odds 
of more n-3 being metabolized, which would lower 
the production of inflammatory eicosanoids. Some 
COX-2 inhibitors have been observed to decrease 
osteoblast differentiation and increase adipogenesis 
(34). This indicates that COX-2 and its lipid products 
may have a role in promoting MSC differentiation into 
adipocytes rather than osteoblasts, and that the ratio 
between n-6-derived COX-2 and n-3-derived COX-2 
products may be important in MSC regulation.
Another proposed mechanism concerns the 
receptor activated nuclear factor kappa-B (RANK) 
signaling and osteoprotegerin (OPG). RANK binds to 
its l igand (RANKL), which is secreted by 
preosteoblasts, and activates osteoclastogenesis and 
bone resorption. Conversely, OPG, which is also 
produced by preosteoblasts, inhibits osteoclastogenesis 
by binding to RANKL, and thus promotes 
osteoblastogenesis. Upregulated pro-inflammatory 
cytokines, including TNF-α, IL-1, and IL-6 in obese 
state seem to mediate osteopenia and osteoporosis by 
regulating the RANKL/RANK/OPG pathway (31, 35).
CONCLUSION
Humans evolved on a diet low in saturated fat, 
carbohydrates, and sodium and much higher in calcium, 
vitamin C, fiber, and phytochemicals. Modern humans, 
however, consume high amounts of n-6 PUFA, about 
10-15 higher than hominines. This elevates the ratio 
between n-6 to n-3 PUFA that stimulates pro-
inflammatory processes and LGCI and promotes the 
pathogenesis of many chronic diseases, including 
obesity and osteoporosis. In contrast, n-3 PUFA and 
their derivatives, consumed by hominines in higher 
amounts, have been shown to promote anti-inflammatory 
processes and to have multiple beneficial health effects.
Obese individuals, who consume greater amounts 
of n-6 PUFA and exhibit higher circulating levels of 
pro-inflammatory cytokines (TNF-α, IL-6, C-RP), 
create the environment of a persistent LGCI, resulting 
in a perpetual feedback cycle. Furthermore, some 
cytokines (e.g. IL-6) stimulate osteoclastogenesis and 
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Figure 2 Further breakdown of fatty acid metabolites and the conversion of eicosanoids to pro- and anti-inflammatory 
products and their roles in the resolution of inflammation. PUFA - polyunsaturated fatty acids; AA - arachidonic acid; 
EPA - eicosapentanoic acid; DHA - docosahexanoic acid
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Figure 3 Hypothetical representation of acute versus low-grade chronic inflammation. The acute process is linear, since 
the inflammation is resolved, whereas the chronic process is a constant cycle in which the inflammation is persistent and 
unresolved. Cytokines are represented by colored shapes. Adapted from (11)
 
Figure 4 The increase in fat mass leads to overproduction of interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosis factor 
alpha (TNF-α). These cytokines increase bone resorption by stimulating the osteoclasts and inhibiting the osteoblasts
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Figure 5 The loop effect of modern (A) and Paleolithic (B) diet on adipogenesis, osteoblastogenesis, and osteoclastogenesis. 
Over-consumption of n-6 PUFA coupled with under-consumption of n-3 PUFA results in increased synthesis of pro-
inflammatory lipid mediators PGE2 and LTB4 by Cox-2 and 5-Lox, leading to peroxisome proliferator-activated receptor 
gamma (PPARγ) signaling, which increases adipogenesis. This in turn produces more TNF-α, resulting in elevated 
osteoclastogenesis, and increases Cox-2 expression directly or indirectly via the platelet activating factor (PAF). Increased 
leptin production by adipose tissue can lower bone formation through its hypothalamic interactions. Furthermore, the 
elevated PGE2 and LTB4 result in an increase in the insulin-like growth factor-binding protein-3 (IGFBP-3), which 
inactivates the insulin-like growth factor-1 and promotes the differentiation of MSC to adipocytes. The net result of these 
events is an increased susceptibility to obesity and osteoporosis. For further review, see (11, 31)
are considered osteoresorptive. Both osteoblasts and 
adipocytes share MSC as their common precursor in 
the bone microenvironment. In conditions of LGCI, 
pro-inflammatory mediators in the presence of a high 
n-6 to n-3 ratio and reactive oxygen species stimulate 
adipogenesis and suppress osteoblastogenesis, shifting 
MSC differentiation toward adipocytes. The presented 
evidence shows that the increased synthesis of pro-
inflammatory cytokines, mediated by the high n-6 to 
n-3 ratios, propagate obesity and osteoporosis by 
increasing or maintaining LGCI. In view of the 
recognized changes in dietary habits of modern humans 
compared to our ancestors, it would be prudent to 
decrease the consumption of n-6 fatty acids toward a 
more beneficial n-6 to n-3 PUFA ratio of 4:1 (as opposed 
to the current 15:1) in order to reduce obesity and 
improve bone health.
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Sažetak
Stalna kronična upala niskoga stupnja zbog suvremenog načina prehrane potiče pretilost i 
osteoporozu
Pojedina univerzalna svojstva prehrane hominina prije pojave poljodjelstva izrazito se razlikuju od 
suvremene prehrane. Prehrambene navike hominina vjerojatno su bile ograničene na plodove divljeg bilja 
i lovinu; više od 70 % moderne prehrane odnosi se na konzumaciju rafiniranih šećera, biljnih ulja, žitarica 
i mliječnih prerađevina. Moderna je prehrana s višim unosom masti također dovela do nepovoljnijeg omjera 
omega-6 i omega-3 višestruko nezasićenih masnih kiselina (engl. krat. PUFA), koji pridonosi održavanju 
kronične upale niskoga stupnja, a time i nastanku mnogih kroničnih bolesti, uključujući pretilost i 
osteoporozu. U ovom se preglednom članku opisuju promjene uslijed modernog načina prehrane, s posebnim 
osvrtom na vrste i količine konzumirane masti. Također se objašnjavaju nedostatci moderne prehrane s 
obzirom na upalne procese te međusobna povezanost između pretilosti i upalnih procesa, koji su usto i 
poveznica između pretilosti i osteoporoze. U članku se iznose saznanja o tome da pretjerana konzumacija 
omega-6 masnih kiselina uz nedostatnu konzumaciju omega-3 masnih kiselina dovodi do kronične upale 
niskoga stupnja i povišenih vrijednosti reaktivnih kisikovih čestica (ROS), a time i do pomaka u 
mezenhimskih matičnih stanica (prekursora osteoblasta i adipocita) prema povećanoj adipogenezi i 
smanjenoj osteoblastogenezi. Uz povećanu sintezu upalnih citokina zbog pretilosti, moderna prehrana s 
nepovoljnim omjerom omega-6 i omega-3 kiselina u korist prvih nastavlja poticati pretilost i osteoporozu 
jer održava i pogoršava kroničnu upalu.
KLJUČNE RIJEČI: adipociti; citokini; ikosanoidi; mezenhimske matične stanice; omega-3 masne 
kiseline; omega-6 masne kiseline; osteoblasti; osteoklasti; višestruko nezasićene masne kiseline
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